Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder	Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autism spectrum disorder, communication disorder, language disorder, nervous system disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder	Active, not recruiting	Phase 2	2026-04-27		NCT02839915

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Emory University	393
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	536
Harvard University	37
Southwest Autism Research & Resource Center	6
State University of New York - Downstate Medical Center	9

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Healtcare of Atlanta	Atlanta	United States	1
Harvard University	Lexington	United States	1
Southwestern Research and Resource Center	Phoenix	United States	2
State University of New York, Downstate	Brooklyn	United States	4